|
|
| Y-15 / Roswell Park Comprehensive Cancer Center (0 Trials) |
|
| Y-PEG IFN- α 2a / Xiamen Amoytop Biotech, BioGeneric Pharma (0 Trials) |
|
| Y101D / YZY Biopharma (0 Trials) |
|
| Y111 / CSPC Pharma (0 Trials) |
|
| Y150 / YZY Biopharma (0 Trials) |
|
| Y242 / Imperial College London (0 Trials) |
|
| YA-101 / National Taiwan University, Yoda Pharma (0 Trials) |
|
| Yallaferon (recombinant human interferon α-2b gel) / Lee's Pharm (0 Trials) |
|
| YB-1113 / YB Life Sci, Bright Cell (0 Trials) |
|
| YB-200 / Ymmunobio (0 Trials) |
|
| YB-800 / Ymmunobio (0 Trials) |
|
| YBL-003 / Y-Biologics, Pierre Fabre (0 Trials) |
|
| YBL-008 / Y-Biologics (0 Trials) |
|
| YBL-009 / Y-Biologics (0 Trials) |
|
| YBL-011 / Y-Biologics (0 Trials) |
|
| YBL-013 / Y-Biologics (0 Trials) |
|
| YBL-015 / Y-Biologics, IntoCell (0 Trials) |
|
| YBL-016 / Y-Biologics (0 Trials) |
|
| YBL-017 / Y-Biologics (0 Trials) |
|
| YBL-018 / Y-Biologics, NeoImmuneTech (0 Trials) |
|
| YBL-019 / Y-Biologics (0 Trials) |
|
| YBL-020 / Y-Biologics (0 Trials) |
|
| YBL-027 / Y-Biologics (0 Trials) |
|
| YBL-031 / Y-Biologics (0 Trials) |
|
| YBL-032 / Y-Biologics (0 Trials) |
|
| YBSW015 / Yabao Pharma (0 Trials) |
|
| Ycanth (cantharidin) / Verrica (0 Trials) |
|
| YD 314 / YD Global (0 Trials) |
|
| YD-309 / YD Global (0 Trials) |
|
| YD-313 / YD Global (0 Trials) |
|
| YE-NEO 001 / ImmunityBio (0 Trials) |
|
| Yeliva (opaganib) / Apogee Biotech, RedHill (3 Trials) |
|
| yellow fever vaccine / iBio, Fraunhofer Institute for Molecular Biology and Applied Ecology, Oswaldo Cruz Foundation (3 Trials) |
|
| Yervoy (ipilimumab) / Ono Pharma, BMS (418 Trials) |
|
| Yesafili (aflibercept biosimilar) / J&J, Biocon (0 Trials) |
|
| Yescarta (axicabtagene ciloleucel) / Gilead (20 Trials) |
|
| YF-VAX (yellow fever vaccine) / Sanofi (0 Trials) |
|
| YF17D vector based coronavirus vaccine / University of Leuven, Batavia Biosci (0 Trials) |
|
| YF2 / Columbia University Irving Medical Center (0 Trials) |
|
| YG1699 / Youngene Therap (0 Trials) |
|
| YH-NCE4 / Yuhan Corp (0 Trials) |
|
| YH001 / Biocytogen (0 Trials) |
|
| YH002 / Biocytogen, Syncromune (0 Trials) |
|
| YH003 / Biocytogen (0 Trials) |
|
| YH004 / Biocytogen (0 Trials) |
|
| YH006 / Biocytogen (0 Trials) |
|
| YH008 / Biocytogen (0 Trials) |
|
| YH010 / Biocytogen (0 Trials) |
|
| YH011 / Biocytogen, GeneQuantum Healthcare (0 Trials) |
|
| YH012 / Biocytogen, Radiance Biopharma (0 Trials) |
|
| YH23537 / Yuhan Corp (0 Trials) |
|
| YH25248 / Yuhan Corp (0 Trials) |
|
| YH25487 / Yuhan Corp (0 Trials) |
|
| YH29143 / Yuhan Corp (0 Trials) |
|
| YH29407 / Yuhan Corp (0 Trials) |
|
| YH32364 / Yuhan Corp, ABL Bio (0 Trials) |
|
| YH34160 / Yuhan Corp (0 Trials) |
|
| YH36425 / Yuhan Corp (0 Trials) |
|
| YH38560 / Yuhan Corp (0 Trials) |
|
| YHB1411-2 / Yuhan Corp (0 Trials) |
|
| YHC1116 / Yuhan Corp (0 Trials) |
|
| YHC2127 / Yuhan Corp, Imnewrun Biosci (0 Trials) |
|
| YHC2133 / Yuhan Corp (0 Trials) |
|
| YHO-1701 / Yakult Honsha (0 Trials) |
|
| Yi Bao EPO (epoetin alfa biosimilar) / Fosun Pharma (0 Trials) |
|
| yifenidone (HEC585) / HEC Pharm (1 Trials) |
|
| yimitasvir (DAG181) / Dongguan HEC TaiGen Biopharma, HEC Pharm (0 Trials) |
|
| Yinhu Qingwen Granula / Guang'anmen Hospital (0 Trials) |
|
| yinlitinib / HEC Pharm (0 Trials) |
|
| Yinuokai (orelabrutinib) / InnoCare, Biogen (1 Trials) |
|
| yiqibuvir (HEC110114) / HEC Pharm (0 Trials) |
|
| Yisaipu (etanercept biosimilar) / Cipla, 3SBio, Abbott (4 Trials) |
|
| YIV-906 / Yiviva, Sanofi (1 Trials) |
|
| Yivyka (polyinosinic-polycytidylic acid/inactivated rabies virus for injection) / YS Biopharma (0 Trials) |
|
| YK-2168 / Damei Biopharma, WuXi AppTec (0 Trials) |
|
| YKP-10461 / SK Bio (0 Trials) |
|
| YKP1447 / SK Bio (0 Trials) |
|
| YL-13027 / Shanghai YingLi Pharma (0 Trials) |
|
| YL-15293 / Shanghai YingLi Pharma (0 Trials) |
|
| YL201 / MediLink (0 Trials) |
|
| YM 231146 / Astellas (0 Trials) |
|
| YM 57158 / Astellas (0 Trials) |
|
| YM-254890 / Astellas (0 Trials) |
|
| YM-359445 / Astellas (0 Trials) |
|
| YM-393059 / Astellas (0 Trials) |
|
| YM-53601 / Astellas (0 Trials) |
|
| YM311 / Astellas, FibroGen (0 Trials) |
|
| YNT-185 / University of Tsukuba (0 Trials) |
|
| Yondelis (trabectedin) / Otsuka, PharmaMar, Valeo Pharma, J&J (39 Trials) |
|
| Yonsa (abiraterone acetate) / Churchill Pharma, Sun Pharma (3 Trials) |
|
| Yorvipath (palopegteriparatide) / Ascendis (0 Trials) |
|
| Young TIL / National Cancer Institute (0 Trials) |
|
| Youshu (sumatriptan succinate) / Simcere (0 Trials) |
|
| YP 005 / York Pharma (0 Trials) |
|
| YP-P10 / Yuyu Pharma (0 Trials) |
|
| YP004 / York Pharma (0 Trials) |
|
| YP006 / York Pharma (0 Trials) |
|
| YP007 / York Pharma (0 Trials) |
|
| YP008 / York Pharma (0 Trials) |
|
| YP009 / York Pharma (0 Trials) |
|
| YP010 / York Pharma (0 Trials) |
|
| YP01001 / Fosun Pharma (0 Trials) |
|
| YPEG-filgrastim (YPEG-rhG-CSF) / Xiamen Amoytop Biotech (0 Trials) |
|
| YPF-1827 / KT&G Corp (0 Trials) |
|
| YPI 011 / KT&G Corp (0 Trials) |
|
| YPN-005 / KT&G Corp (0 Trials) |
|
| YPT-01 / Felix Biotech (0 Trials) |
|
| YQ23 / New Beta Innovation (0 Trials) |
|
| YR-005 / Hangzhou Yirui Pharma (0 Trials) |
|
| YR-006 / Hangzhou Yirui Pharma (0 Trials) |
|
| YR001 / Hangzhou Yirui Pharma (0 Trials) |
|
| YS-HBV-001 / YS Biopharma (0 Trials) |
|
| YS-HBV-002 / YS Biopharma (0 Trials) |
|
| YS-ON-002 / YS Biopharma (0 Trials) |
|
| YS001 / JiangSu WuZhong Pharma, Hangzhou Yusheng (0 Trials) |
|
| YS110 / Kissei, Y's Therap (0 Trials) |
|
| Yselty (linzagolix) / Kissei, Theramex, Syneos Health (6 Trials) |
|
| YSIL-6 / Y's Therap (0 Trials) |
|
| YT-19 / BriSTAR Immunotech (0 Trials) |
|
| YT-19/22 / BriSTAR Immunotech (0 Trials) |
|
| YTS101 / BriSTAR Immunotech (0 Trials) |
|
| YTS104 / BriSTAR Immunotech, Beijing Qingyi Taike Pharma (0 Trials) |
|
| YTS105 / BriSTAR Immunotech (0 Trials) |
|
| yttrium Y 90 anti-CD19 Ab (BU 12) / National Cancer Institute (0 Trials) |
|
| yttrium Y 90 tabituximab barzuxetan (OTSA101-DTPA-90Y) / OncoTherapy (0 Trials) |
|
| YTX-7739 / J&J (0 Trials) |
|
| YTX-9184 / Kineta (0 Trials) |
|
| Yuanruida (inaticabtagene autoleucel) / CASI, Juventas Cell Therapy (0 Trials) |
|
| Yuflyma (adalimumab-aaty) / Celltrion, Hikma (2 Trials) |
|
| Yupelri (revefenacin) / Theravance Biopharma, Viatris (2 Trials) |
|
| Yusimry (adalimumab-aqvh) / Coherus Biosci (0 Trials) |
|
| Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma (0 Trials) |
|
| Yutuo (zimberelimab) / Arcus Biosci, Gilead (0 Trials) |
|
| YUVA-GT-F801 / SZGIMI (0 Trials) |
|
| YUVA-GT-F901 / SZGIMI (0 Trials) |
|
| YYC405 / Yooyoung Pharma (0 Trials) |
|
| YZJ-1139 / WuXi AppTec, Yangzijiang Pharma (0 Trials) |
|
| YZJ-3058 / Yangzijiang Pharma (0 Trials) |